Impact of TTC Following Neoadjuvant Chemotherapy on the Prognosis of LAGC
he present study retrospectively analyzed the clinicopathological data of 524 patients diagnosed with LAGC who underwent D2 radical gastrectomy after NACT between January 2010 and December 2021 at 2 centers. This study was conducted in accordance with the ethical principles outlined in the World Medical Association's Declaration of Helsinki. Informed consent was obtained from all patients and their legal guardians. All procedures were approved by the institutional review board.
Gastric Cancer
3-year all-caused mortality, 3-year Gastric-Cancer Specific Motality, Survival status at 3 years: survival, death, survival with tumor, 3 years or 36 months.
This is a retrospective, multicenter study.